Hydracarbazine

DB09243ExperimentalSmall molecule

Hydracarbazine is a pyridazine that has found use as an antihypertensive agent It was once marketed in France under the tradename Normatensyl.

Mechanism: Likely acts similarly to hydralazine, a related compound, which interferes with calcium release from the sarcoplasmic reticulum in response to inositol.
Curator reviewed · 1 reference
Primary indication: Was used for the treatment of hypertension.Curator reviewed
Formula / weight: C₅H₇N₅O · 153.145 g/mol (avg)
Code names: TH-2151

Resolves to

Compound

Structure

InChIKeyWRYZEGZNBYOMLE-UHFFFAOYSA-NSMILES[H]N([H])N([H])C1=NN=C(C=C1)C(=O)N([H])[H]

What you can answer from here — as of February 21, 2021

1,331Drug interactionsStructured to mechanism, not free text

2+ReferencesStructured and connected to the statements they support

Which companies are running trials of Hydracarbazine, in which indications and phases, and which of those programs are still active?

Create a free account or log in to explore the full data card.